Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

The decision means Germany's GAIA will regain rights to the DTx, called Deprexis, in the US, and comes as the American market for digital health technologies continues to be hampered by an ...

DTX Exchange is redefining crypto trading with its dual-chain infrastructure, bridging traditional finance and DeFi. As one of the most anticipated platforms, DTX Exchange has already raised over ...

The narrowing gap between decentralized and traditional finance is groundbreaking and leading this movement is DTX Exchange (DTX). This innovative trading platform combines key elements of CEX and DEX ...

DTX Exchange is capturing investor attention as one of the best presale opportunities in 2025. The hybrid trading platform is revolutionizing DeFi by offering access to 120,000 financial instruments, ...

DTX Exchange is gaining serious momentum, and its latest presale numbers prove it. Since the announcement of the presale, the exchange has raised over $14 million with more investors flooding in. Soon ...

The crypto market buzz has intensified after DTX Exchange (DTX) saw an incredible 700% presale pump. This increase has many speculating that DTX is the top ICO of the year. Moreover, interest is also ...

With the Cardano price striving to break through key resistance levels and DTX Exchange making waves with its groundbreaking hybrid trading platform, crypto investors are eagerly watching these two ...

DTX Exchange will change the trading markets and bring them into the future. With digital assets growing as fast as they are and becoming popular as investment choices, DTX Exchange has created an ...